Affimed N.V.
Affimed N.V. (AFMDQ) Stock Competitors & Peer Comparison
See (AFMDQ) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AFMDQ | $0.00 | +0.00% | 4.9K | N/A | -$5.33 | N/A |
| NONOF | $46.01 | +1.42% | 203.8B | 10.67 | $4.30 | +3.94% |
| CSLLY | $21.71 | -0.32% | 84.1B | 14.10 | $1.54 | +3.34% |
| UCBJF | $280.85 | +0.32% | 53.5B | 29.85 | $9.41 | +0.61% |
| UCBJY | $138.20 | +2.05% | 52.6B | 29.38 | $4.70 | +0.62% |
| ARGNF | $803.19 | +0.00% | 49.7B | 35.71 | $22.49 | N/A |
| CMXHF | $87.00 | -2.37% | 42.2B | 14.10 | $6.17 | +3.36% |
| WXIBF | $5.25 | +29.63% | 21.7B | 30.88 | $0.17 | N/A |
| IVBXF | $10.30 | -10.04% | 17.9B | 147.14 | $0.07 | N/A |
| WXXWY | $8.26 | -1.67% | 17.1B | 24.38 | $0.34 | N/A |
Stock Comparison
AFMDQ vs NONOF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, NONOF has a market cap of 203.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while NONOF trades at $46.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 10.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, AFMDQ is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check NONOF's competition here
AFMDQ vs CSLLY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CSLLY has a market cap of 84.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while CSLLY trades at $21.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 14.10. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, AFMDQ is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CSLLY's competition here
AFMDQ vs UCBJF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, UCBJF has a market cap of 53.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while UCBJF trades at $280.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 29.85. In terms of profitability, AFMDQ's ROE is -1.01%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, AFMDQ is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check UCBJF's competition here
AFMDQ vs UCBJY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, UCBJY has a market cap of 52.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while UCBJY trades at $138.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 29.38. In terms of profitability, AFMDQ's ROE is -1.01%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, AFMDQ is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check UCBJY's competition here
AFMDQ vs ARGNF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, AFMDQ is priced at $0.00, while ARGNF trades at $803.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 35.71. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, AFMDQ is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ARGNF's competition here
AFMDQ vs CMXHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CMXHF has a market cap of 42.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while CMXHF trades at $87.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 14.10. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, AFMDQ is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CMXHF's competition here
AFMDQ vs WXIBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, AFMDQ is priced at $0.00, while WXIBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 30.88. In terms of profitability, AFMDQ's ROE is -1.01%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check WXIBF's competition here
AFMDQ vs IVBXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, IVBXF has a market cap of 17.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while IVBXF trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is 147.14. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, AFMDQ is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check IVBXF's competition here
AFMDQ vs WXXWY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, WXXWY has a market cap of 17.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while WXXWY trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 24.38. In terms of profitability, AFMDQ's ROE is -1.01%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check WXXWY's competition here
AFMDQ vs GNMSF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GNMSF has a market cap of 15.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while GNMSF trades at $259.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 16.87. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, AFMDQ is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GNMSF's competition here
AFMDQ vs SBHMY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SBHMY has a market cap of 12.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SBHMY's competition here
AFMDQ vs SBMFF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, AFMDQ is priced at $0.00, while SBMFF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 23.20. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SBMFF's competition here
AFMDQ vs BRRGF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, AFMDQ is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BRRGF's competition here
AFMDQ vs AAVXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, AFMDQ is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check AAVXF's competition here
AFMDQ vs ODTC Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, AFMDQ is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is 1.07. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, AFMDQ is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ODTC's competition here
AFMDQ vs AKBLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, AKBLF has a market cap of 7.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while AKBLF trades at $35.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 39.07. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, AFMDQ is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check AKBLF's competition here
AFMDQ vs TRSBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while TRSBF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 5.70. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, AFMDQ is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check TRSBF's competition here
AFMDQ vs REGMF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is 51.63. In terms of profitability, AFMDQ's ROE is -1.01%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, AFMDQ is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check REGMF's competition here
AFMDQ vs ABCZF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, AFMDQ is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ABCZF's competition here
AFMDQ vs LABFF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, AFMDQ's ROE is -1.01%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, AFMDQ is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check LABFF's competition here
AFMDQ vs SHJBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, AFMDQ is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SHJBF's competition here
AFMDQ vs CAMRF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CAMRF has a market cap of 3.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while CAMRF trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 47.95. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, AFMDQ is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CAMRF's competition here
AFMDQ vs ZLDPF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ZLDPF has a market cap of 3.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while ZLDPF trades at $53.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is 3.79. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, AFMDQ is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ZLDPF's competition here
AFMDQ vs TLPPF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, TLPPF has a market cap of 3.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while TLPPF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is -525.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, AFMDQ is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check TLPPF's competition here
AFMDQ vs ASPHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, AFMDQ is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ASPHF's competition here
AFMDQ vs INCPF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while INCPF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is 34.17. In terms of profitability, AFMDQ's ROE is -1.01%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, AFMDQ is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check INCPF's competition here
AFMDQ vs GNNSF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while GNNSF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -5.60. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, AFMDQ is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GNNSF's competition here
AFMDQ vs BRCTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 26.63. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, AFMDQ is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BRCTF's competition here
AFMDQ vs MPSYF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, AFMDQ is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check MPSYF's competition here
AFMDQ vs BVNKF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, AFMDQ is priced at $0.00, while BVNKF trades at $30.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 11.12. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BVNKF's competition here
AFMDQ vs BVNRY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while BVNRY trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.71. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, AFMDQ is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BVNRY's competition here
AFMDQ vs ASCLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while ASCLF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -42.84. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, AFMDQ is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ASCLF's competition here
AFMDQ vs MEOBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, AFMDQ is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check MEOBF's competition here
AFMDQ vs HBMHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, HBMHF has a market cap of 2.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while HBMHF trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 21.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, AFMDQ is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check HBMHF's competition here
AFMDQ vs GENSF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while GENSF trades at $31.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is 32.81. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, AFMDQ is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GENSF's competition here
AFMDQ vs GLPGF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, AFMDQ is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GLPGF's competition here
AFMDQ vs PHMMF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, AFMDQ is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PHMMF's competition here
AFMDQ vs BIESF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, AFMDQ is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BIESF's competition here
AFMDQ vs ONTTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while ONTTF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -7.60. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, AFMDQ is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ONTTF's competition here
AFMDQ vs CSPHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CSPHF has a market cap of 1.4B. Regarding current trading prices, AFMDQ is priced at $0.00, while CSPHF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -17.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, AFMDQ is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CSPHF's competition here
AFMDQ vs SNBIF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, AFMDQ is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SNBIF's competition here
AFMDQ vs MDCLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, AFMDQ is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check MDCLF's competition here
AFMDQ vs NURPF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 51.91. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, AFMDQ is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check NURPF's competition here
AFMDQ vs IDRSF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -3.30. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, AFMDQ is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check IDRSF's competition here
AFMDQ vs CSBTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CSBTF has a market cap of 989.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while CSBTF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is 315.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, AFMDQ is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CSBTF's competition here
AFMDQ vs PPTDF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PPTDF has a market cap of 980.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while PPTDF trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is -42.17. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, AFMDQ is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PPTDF's competition here
AFMDQ vs BTTAY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, AFMDQ is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, AFMDQ is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BTTAY's competition here
AFMDQ vs PHGUF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PHGUF has a market cap of 880.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while PHGUF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -124.72. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, AFMDQ is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PHGUF's competition here
AFMDQ vs TKBIF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, AFMDQ is priced at $0.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is -21.47. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TKBIF's ROE of N/A. Regarding short-term risk, AFMDQ is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check TKBIF's competition here
AFMDQ vs BPMUF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BPMUF has a market cap of 846.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while BPMUF trades at $69.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, AFMDQ is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BPMUF's competition here
AFMDQ vs IVEVF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while IVEVF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -2.47. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, AFMDQ is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check IVEVF's competition here
AFMDQ vs SOLTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SOLTF has a market cap of 605.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while SOLTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -7.60. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, AFMDQ is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SOLTF's competition here
AFMDQ vs CKDXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, AFMDQ is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CKDXF's competition here
AFMDQ vs INRLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, INRLF has a market cap of 480.1M. Regarding current trading prices, AFMDQ is priced at $0.00, while INRLF trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -3.49. In terms of profitability, AFMDQ's ROE is -1.01%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, AFMDQ is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check INRLF's competition here
AFMDQ vs GNFTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while GNFTF trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is -4.69. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, AFMDQ is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GNFTF's competition here
AFMDQ vs RAONF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, AFMDQ's ROE is -1.01%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, AFMDQ is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check RAONF's competition here
AFMDQ vs CYDY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CYDY has a market cap of 448.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while CYDY trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -8.21. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, AFMDQ is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CYDY's competition here
AFMDQ vs GNFTY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, AFMDQ is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check GNFTY's competition here
AFMDQ vs BOVNF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, AFMDQ is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BOVNF's competition here
AFMDQ vs TBGNF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, AFMDQ is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check TBGNF's competition here
AFMDQ vs VBIZF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, VBIZF has a market cap of 427.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while VBIZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 20.27. In terms of profitability, AFMDQ's ROE is -1.01%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, AFMDQ is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check VBIZF's competition here
AFMDQ vs AVCTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, AVCTF has a market cap of 425M. Regarding current trading prices, AFMDQ is priced at $0.00, while AVCTF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -6.48. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, AFMDQ is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check AVCTF's competition here
AFMDQ vs PTCHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PTCHF has a market cap of 411.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while PTCHF trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is -3.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, AFMDQ is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PTCHF's competition here
AFMDQ vs NWPHF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, AFMDQ is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check NWPHF's competition here
AFMDQ vs NWBO Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, NWBO has a market cap of 376M. Regarding current trading prices, AFMDQ is priced at $0.00, while NWBO trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -5.85. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, AFMDQ is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check NWBO's competition here
AFMDQ vs CLVLY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CLVLY has a market cap of 343.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while CLVLY trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 14.82. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, AFMDQ is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CLVLY's competition here
AFMDQ vs CLVLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CLVLF has a market cap of 343.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while CLVLF trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.82. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, AFMDQ is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CLVLF's competition here
AFMDQ vs SLNCF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while SLNCF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -3.75. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SLNCF's ROE of -1.85%. Regarding short-term risk, AFMDQ is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SLNCF's competition here
AFMDQ vs SPHDF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SPHDF has a market cap of 330.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -4.85. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, AFMDQ is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SPHDF's competition here
AFMDQ vs NGENF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -15.19. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, AFMDQ is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check NGENF's competition here
AFMDQ vs FGHQF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, AFMDQ is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check FGHQF's competition here
AFMDQ vs PBBIF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, AFMDQ is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PBBIF's competition here
AFMDQ vs KNTPF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, KNTPF has a market cap of 265M. Regarding current trading prices, AFMDQ is priced at $0.00, while KNTPF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -9.42. In terms of profitability, AFMDQ's ROE is -1.01%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, AFMDQ is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check KNTPF's competition here
AFMDQ vs ORPOF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ORPOF's ROE of N/A. Regarding short-term risk, AFMDQ is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ORPOF's competition here
AFMDQ vs HNSBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -3.37. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, AFMDQ is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check HNSBF's competition here
AFMDQ vs OPORF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 35.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to OPORF's ROE of -0.15%. Regarding short-term risk, AFMDQ is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check OPORF's competition here
AFMDQ vs SPHRY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SPHRY has a market cap of 239.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHRY trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHRY's P/E ratio is -95.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, AFMDQ is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SPHRY's competition here
AFMDQ vs HLOSF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, HLOSF has a market cap of 236.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while HLOSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -12.94. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, AFMDQ is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check HLOSF's competition here
AFMDQ vs SCNLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SCNLF has a market cap of 236.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while SCNLF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -22.80. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, AFMDQ is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SCNLF's competition here
AFMDQ vs ORYZF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, AFMDQ is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ORYZF's competition here
AFMDQ vs CMVLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, AFMDQ is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check CMVLF's competition here
AFMDQ vs FPHAF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, AFMDQ is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check FPHAF's competition here
AFMDQ vs RECEF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -8.33. In terms of profitability, AFMDQ's ROE is -1.01%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, AFMDQ is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check RECEF's competition here
AFMDQ vs ADOCY Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, AFMDQ is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ADOCY's competition here
AFMDQ vs BBIXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BBIXF has a market cap of 163.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while BBIXF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BBIXF's P/E ratio is -14.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, AFMDQ is more volatile compared to BBIXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BBIXF's competition here
AFMDQ vs JWCTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, JWCTF has a market cap of 147.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while JWCTF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.78. In terms of profitability, AFMDQ's ROE is -1.01%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, AFMDQ is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check JWCTF's competition here
AFMDQ vs SPHRF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, AFMDQ is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check SPHRF's competition here
AFMDQ vs AMGXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, AFMDQ is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check AMGXF's competition here
AFMDQ vs IPHYF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.34. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, AFMDQ is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check IPHYF's competition here
AFMDQ vs BRIBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, AFMDQ is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check BRIBF's competition here
AFMDQ vs HBPCF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, AFMDQ is priced at $0.00, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, AFMDQ is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check HBPCF's competition here
AFMDQ vs AAPGV Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, AFMDQ is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check AAPGV's competition here
AFMDQ vs TRGNF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, AFMDQ is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check TRGNF's competition here
AFMDQ vs PSTTF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PSTTF's ROE of N/A. Regarding short-term risk, AFMDQ is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check PSTTF's competition here
AFMDQ vs ATGGF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ATGGF has a market cap of 113.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ATGGF's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, AFMDQ is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ATGGF's competition here
AFMDQ vs EPRXF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, AFMDQ's ROE is -1.01%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, AFMDQ is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check EPRXF's competition here
AFMDQ vs POLBF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, POLBF has a market cap of 106.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while POLBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas POLBF's P/E ratio is -15.10. In terms of profitability, AFMDQ's ROE is -1.01%, compared to POLBF's ROE of -0.54%. Regarding short-term risk, AFMDQ is more volatile compared to POLBF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check POLBF's competition here
AFMDQ vs ADOIF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, AFMDQ is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check ADOIF's competition here
AFMDQ vs MSCLF Comparison May 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 4.9K. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, AFMDQ is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AFMDQ.Check MSCLF's competition here